Spectrum Spine announced that its BioBraille technology received nanotechnology designation from FDA. It is reported to be the only nanotechnology with selective surface capabilities.
Utilizing a proprietary and advanced laser etching process to “program” macro-, micro-, and nanofeatures onto the implant surface, BioBraille has demonstrated an amplified biologic response in vitro with an abundance of nanofeatures in an advantageous size range to promote cellular attachment and early phase bone production.
Spectrum has enhanced the precision and versatility of nanotechnology integration by enabling targeted application of its proprietary BioBraille surface. BioBraille is accomplished through a femtosecond laser etching process that is highly prescriptive and reproducible. The surface does not shear under stress and demonstrates exceptional dimensional accuracy. This approach allows for strategic placement on implant areas requiring immediate bone contact and fusion, while preserving smooth, polished, or articulating surfaces to maintain optimal mobility and performance.
Spectrum has released its anterior cervical cage incorporating BioBraille, with release of an expandable interbody cage and family of lumbar cages to follow.
Spectrum Spine announced that its BioBraille technology received nanotechnology designation from FDA. It is reported to be the only nanotechnology with selective surface capabilities.
Utilizing a proprietary and advanced laser etching process to "program" macro-, micro-, and nanofeatures onto the implant surface, BioBraille has...
Spectrum Spine announced that its BioBraille technology received nanotechnology designation from FDA. It is reported to be the only nanotechnology with selective surface capabilities.
Utilizing a proprietary and advanced laser etching process to “program” macro-, micro-, and nanofeatures onto the implant surface, BioBraille has demonstrated an amplified biologic response in vitro with an abundance of nanofeatures in an advantageous size range to promote cellular attachment and early phase bone production.
Spectrum has enhanced the precision and versatility of nanotechnology integration by enabling targeted application of its proprietary BioBraille surface. BioBraille is accomplished through a femtosecond laser etching process that is highly prescriptive and reproducible. The surface does not shear under stress and demonstrates exceptional dimensional accuracy. This approach allows for strategic placement on implant areas requiring immediate bone contact and fusion, while preserving smooth, polished, or articulating surfaces to maintain optimal mobility and performance.
Spectrum has released its anterior cervical cage incorporating BioBraille, with release of an expandable interbody cage and family of lumbar cages to follow.
Copy to clipboard 
